Elucidation of mechanism for the enhancement of osteoclast differentiation under hypoxia and development of new therapeutic approach for bone resorption in rheumatoid arthritis
Project/Area Number |
18H02926
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Review Section |
Basic Section 56020:Orthopedics-related
|
Research Institution | Kyoto University |
Principal Investigator |
Murata Koichi 京都大学, 医学研究科, 特定助教 (60806793)
|
Co-Investigator(Kenkyū-buntansha) |
吉富 啓之 京都大学, 医学研究科, 准教授 (50402920)
寺尾 知可史 国立研究開発法人理化学研究所, 生命医科学研究センター, チームリーダー (60610459)
伊藤 宣 京都大学, 医学研究科, 特定教授 (70397537)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥16,900,000 (Direct Cost: ¥13,000,000、Indirect Cost: ¥3,900,000)
Fiscal Year 2020: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Fiscal Year 2018: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
|
Keywords | 破骨細胞 / 低酸素 / 関節リウマチ / 骨粗鬆症 / 炎症性疾患 / SNP |
Outline of Final Research Achievements |
The purpose of this study was to comprehensively elucidate the mechanism of promoting osteoclast differentiation under hypoxia and to search for a therapeutic method for bone destruction specific to rheumatoid arthritis. We found that KDM1a is important using specific siRNAs and inhibitors. KDM1a is mTOR-dependently induced by RANKL stimulation during osteoclastogenesis. KDM1a regulated metabolism in HIF1-mediated osteoclast differentiation not only under hypoxia but also under normoxia. Furthermore, it regulated the expression of E2F1 regulating the cell cycle and metabolism in osteoclast differentiation. The HIF-mediated osteoclast differentiation pathway of KDM1a was found to be important in inflammatory bone resorption, including rheumatoid arthritis.
|
Academic Significance and Societal Importance of the Research Achievements |
関節リウマチは炎症性疾患で、骨軟骨破壊を来して、機能障害を引き起こす。近年様々な薬剤が開発されたものの、骨破壊は完全には制御できておらず、既存の治療は副作用や長期使用に問題がある。今回、骨を破壊する細胞の主軸である破骨細胞の分化において、KDM1aが重要であることが分かった。KDM1aを介した炎症部位特異的な骨破壊の機序が明らかになり、今後関節リウマチの新たな骨破壊の治療法になる可能性がある。
|
Report
(4 results)
Research Products
(47 results)
-
-
-
-
-
[Journal Article] A VCP modulator, KUS121, as a promising therapeutic agent for post-traumatic osteoarthritis.2020
Author(s)
Saito M, Nishitani K, Ikeda HO, Yoshida S, Iwai S, Ji X, Nakahata A, Ito A, Nakamura S, Kuriyama S, Yoshitomi H, Murata K, Aoyama T, Ito H, Kuroki H, Kakizuka A, Matsuda S.
-
Journal Title
Scientific Reports
Volume: 10
Issue: 1
Pages: 20787-20787
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis.2020
Author(s)
Murakami K, Murakami I*, Hashimoto M, Tanaka M, Ito H, Fujii T, Torii M, Ikeda K, Kuwabara A, Tanaka K, Yoshida A, Akizuki S, Nakashima R, Yoshifuji H, Ohmura K, Usui T, Morita S, Mimori T
-
Journal Title
PLoS One
Volume: 15
Issue: 2
Pages: 0228852-0228852
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
[Journal Article] Strain-specific manifestation of lupus-like systemic autoimmunity caused by ZAP70 mutation2019
Author(s)
Takashi Matsuo, Motomu Hashimoto, Shimon Sakaguchi, Noriko Sakaguchi, Yoshinaga Ito, Masaki Hikida, Tatsuaki Tsuruyama, Kaoru Sakai, Hideki Yokoi, Mirei Shirakashi, Masao Tanaka, Hiromu Ito, Hajime Yoshifuji, Koichiro Ohmura, Takao Fujii, and Tsuneyo Mimori
-
Journal Title
The Journal of Immunology
Volume: 印刷中
Issue: 11
Pages: 3161-3172
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Human Sox4 facilitates the development of CXCL13-producing helper T cells in inflammatory environments.2018
Author(s)
Yoshitomi H, Kobayashi S, Miyagawa-Hayashino A, Okahata A, Doi K, Nishitani K, Murata K, Ito H, Tsuruyama T, Haga H, Matsuda S, Toguchida J
-
Journal Title
Nature Communications
Volume: 9
Issue: 1
Pages: 3762-3762
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis.2018
Author(s)
Nakagawa S, Nakaishi M, Hashimoto M, Ito H, Yamamoto W, Nakashima R, Tanaka M, Fujii T, Omura T, Imai S, Nakagawa T, Yonezawa A, Imai H, Mimori T, Matsubara K.
-
Journal Title
PLoS One
Volume: 13
Issue: 11
Pages: e0206943-e0206943
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.2018
Author(s)
Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, et al.
-
Journal Title
Proc Natl Acad Sci U S A
Volume: 115
Issue: 51
Pages: 13045-13050
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Presentation] Real-world effectiveness of denosumab on clinical fracture reduction in patients with rheumatoid arthritis-ANSWER cohort study2020
Author(s)
Koichi Murata, Motomu Hashimoto, Kosuke Ebina, Kengo Akashi, Akira Onishi, Koji Nagai, Ayaka Yoshikawa, Masaki Katayama, Yonsu Son, Hideki Amuro, Ryota Hara, Wataru Yamamoto, Kosaku Murakami, Masao Tanaka, Hiromu Ito, and Shuichi Matsuda
Organizer
第64回日本リウマチ学会総会・学術集会
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-